Related Experiment Video
Updated: May 21, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
[Immunodeficiency and Central Nervous System Infections]
1Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 19, 2026
Summary
Central nervous system (CNS) infections pose severe risks for immunocompromised patients, including transplant recipients and those with Human Immunodeficiency Virus (HIV). Prompt recognition and management are crucial for improving outcomes in these vulnerable populations.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Central nervous system (CNS) infections are critical complications in immunocompromised individuals.
- Immunodeficiency arises from conditions like organ transplantation, stem cell transplantation, and Human Immunodeficiency Virus (HIV) infection.
- Therapies including steroids, immunosuppressants, and anti-complement or anti-B cell treatments increase susceptibility to CNS infections.
Purpose of the Study:
- To review the clinical presentation and management strategies for CNS infections in specific immunocompromised patient groups.
- To provide guidance for neurologists managing opportunistic infections in vulnerable populations.
- To consolidate information on CNS infection management across various immunosuppressive states.
Main Methods:
- Literature review focusing on clinical information and management of CNS infections.
- Analysis of data pertaining to organ transplant recipients, hematopoietic stem cell transplant recipients, and patients with HIV.
- Examination of infection management in patients undergoing specific immunosuppressive therapies.
Main Results:
- CNS infections present significant challenges in immunocompromised patients.
- Early detection and vigilant monitoring are essential for effective patient care.
- Management strategies must be tailored to the underlying cause of immunodeficiency and specific pathogens.
Conclusions:
- Neurologists must maintain a high index of suspicion for CNS infections in immunocompromised patients.
- Comprehensive understanding of predisposing factors and treatment modalities is vital.
- Proactive management is key to mitigating the life-threatening potential of CNS infections in these settings.
More Related Videos
Related Concept Videos
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...